Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
Ist Teil von
The New England journal of medicine, 2008-12, Vol.359 (24), p.2567-2578
Ort / Verlag
Waltham, MA: Massachusetts Medical Society
Erscheinungsjahr
2008
Quelle
MEDLINE
Beschreibungen/Notizen
This trial tested the influence of aspirin or resistant starch on the incidence of colorectal cancer or colonic adenomas in patients with the Lynch syndrome (hereditary nonpolyposis colon cancer). Neither intervention influenced the incidence of colorectal neoplasms in the Lynch syndrome.
Neither aspirin or resistant starch influenced the incidence of colorectal neoplasms in the Lynch syndrome.
The regular use of aspirin or aspirin-like agents is associated with a moderate reduction in the risk of colonic polyps and colorectal cancer.
1
–
4
Randomized trials of high-fiber diets have not shown a reduction in the risk of adenomas or colorectal cancer,
5
but none have investigated the effects of resistant starch. There is epidemiologic evidence of a negative correlation between colon cancer and starch intake.
6
Resistant starches escape digestion in the upper gut; colonic fermentation yields short-chain fatty acids, including butyrate, which has antineoplastic properties.
7
In carcinogen-treated rats, resistant starch reduces the development of intestinal tumors
8
,
9
and the production . . .